Hepatocellular Carcinoma Clinical Trials

ReadTheTrial indexes 1 studies for Hepatocellular Carcinoma. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Hepatocellular Carcinoma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for Hepatocellular Carcinoma

Bevacizumab Plus Iparomlimab/Tuvonralimab With Hepatic Artery Infusion Chemotherapy Followed by Stereotactic Body Radiotherapy in Patients With BCLC Stage C Hepatocellular Carcinoma With Thrombus and/or Extrahepatic Oligometastases (BITS-TO-HCC): Study Protocol of a Prospective, Multicenter, Single-Arm, Phase II Study

NCT07062055 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Hepatocellular Carcinoma?

There are 1 clinical trials listed for Hepatocellular Carcinoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Hepatocellular Carcinoma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Hepatocellular Carcinoma trials in?

Current Hepatocellular Carcinoma trials are distributed across: Phase 2 (1).

Find More Trials